An international research team has demonstrated that a new plant-derived drug can block the progression of multiple sclerosis (MS).
University of Queensland researcher Dr Christian Gruber said the breakthrough could be a step forward in preventing and treating MS and other autoimmune diseases.
“This is a really exciting discovery because it may offer a whole new quality of life for people with this debilitating disease,” he said.
The new drug is expected to be taken by mouth, in contrast to some current MS treatments where patients need to have frequent injections.
MS is a chronic incurable condition marked by attacks that bring gradual deterioration in the patient’s health. About 23,000 people are affected in Australia and 2.5 million worldwide.
Dr Gruber said the new drug – named T20K – was extracted from a traditional medicinal plant, the Oldenlandia affinis.
The drug treatment had been successful in an animal model, and patent applications filed in several countries.
“Phase one clinical trials could begin as early as 2018,” Dr Gruber said.
“Licences have been assigned to Cyxone, a company established last year to develop this new class of drugs for the treatment of autoimmune diseases.
“Cyxone’s immediate focus is on bringing T20K through the pre-clinical program required for delivering a safe, orally active drug.”
Dr Gruber said the new treatment arose from a synthesised plant peptide, a class of drugs known as cyclotides.
“Cyclotides are present in a range of common plants, and they show significant potential for the treatment of auto immune diseases,” he said.
“The T20K peptides exhibit extraordinary stability and chemical features that are ideally what you want in an oral drug candidate.”
The international research team demonstrated in an animal model that T20K stopped progression in the normal clinical symptoms of MS.
The Latest on: Multiple sclerosis
via Google News
The Latest on: Multiple sclerosis
- "For the first time in 25 years this means hope" - Leeds family fundraising for life-changing MS treatmenton December 1, 2019 at 10:36 am
A Leeds family are desperately raising funds to help pay for a "life-changing" treatment that could halt the progression of Multiple Sclerosis. Father-of-two Jean-Christophe Verro, 47, lives with MS - ...
- Year in Review: Multiple Sclerosison December 1, 2019 at 9:24 am
Multiple sclerosis (MS) news in 2019 focused largely on drugs -- new drugs, old drugs, drug costs, and treatment strategies -- but new vaccination guidelines and biomarker research also earned ...
- Treatment for multiple sclerosis shows promising signson November 30, 2019 at 12:24 am
Most people know "someone" with multiple sclerosis, with around 10 Australians diagnosed with the autoimmune disease each week. While MS conjures up images of wheelchair bound "sufferers" the reality ...
- Biogen will offer discounts to a health plan if patients say its multiple sclerosis drugs don’t workon November 27, 2019 at 9:06 am
In a twist on value-based contracting, a drug maker has agreed to offer a larger discount that a commercial health plan will receive for medicines – but only based on outcomes that patients report. In ...
- NeurologyLive™ Adds the Consortium of Multiple Sclerosis Centers to Its Strategic Alliance Partnership Programon November 26, 2019 at 4:10 pm
CMSC is an organization of multiple sclerosis health care professionals who strive to improve the lives of those affected by multiple sclerosis (MS). With over 250 member centers in the United ...
- Investigators narrow in on a microRNA for treating multiple sclerosison November 26, 2019 at 8:03 am
It turns out the gut is full of surprises. And one of those surprises may have offered up a key for unlocking a new way of treating multiple sclerosis (MS). Investigators from Brigham and Women's ...
- New method to separate two variants of common herpes virus linked to multiple sclerosison November 26, 2019 at 7:40 am
Researchers at Karolinska Institutet have developed a new method to separate between two different types of a common herpes virus (HHV-6) that has been linked to multiple sclerosis. By analyzing ...
- Multiple sclerosis linked to variant of common herpes virus through new methodon November 26, 2019 at 3:57 am
Researchers at Karolinska Institutet have developed a new method to separate between two types of a common herpes virus (HHV-6) that has been linked to multiple sclerosis (MS). By analyzing antibodies ...
- Multiple Sclerosis Management Challenges and Opportunities: A Q&A With Thomas Leist, MD, PhDon November 25, 2019 at 12:59 pm
Thomas Leist, MD, PhD, Director of the Comprehensive Multiple Sclerosis Center and Professor of Neuroloy at Thomas Jefferson University Hospital, discusses the changing MS therapeutic landscape, the ...
- Study shows the progression of multiple sclerosis can be slowedon November 25, 2019 at 12:07 am
Multiple sclerosis (MS) is difficult to diagnose, and, as yet, it has no cure. However, according to new research, it may be possible to slow its progression without some of the health risks ...
via Bing News